Status:
NOT_YET_RECRUITING
Cardiovascular Protection After Preeclampsia With Enalapril
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Preeclampsia
Hypertensive Disorder of Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensi...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death in women worldwide, and despite declines in all other age groups, mortality rates attributed to CVD are increasing in women of childbearing a...
Eligibility Criteria
Inclusion
- Postpartum individuals
- ≥18 years old
- Hypertensive disorder of pregnancy
- Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program.
Exclusion
- Maternal cardiac disease
- Individuals with pre-pregnancy hypertension or diabetes
- Allergy or contraindication to enalapril
Key Trial Info
Start Date :
November 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07222852
Start Date
November 15 2025
End Date
October 15 2027
Last Update
October 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.